COX-2 is a novel target in therapy of mycosis fungoides

被引:9
作者
Kopp, K. L. M. [1 ,2 ]
Dabelsteen, S. [3 ]
Krejsgaard, T. [1 ,2 ]
Eriksen, K. W. [2 ]
Geisler, C. [2 ]
Becker, J. C. [4 ]
Wasik, M. [5 ]
Odum, N. [1 ,2 ]
Woetmann, A. [1 ,2 ]
机构
[1] Univ Copenhagen, Dept Biol, Copenhagen, Denmark
[2] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[3] Univ Copenhagen, Sch Dent, Dept Oral Pathol & Med, Fac Hlth Sci, Copenhagen, Denmark
[4] Med Univ Graz, Dept Gen Dermatol, Graz, Austria
[5] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1038/leu.2010.221
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2127 / 2129
页数:3
相关论文
共 8 条
[1]   Mycosis fungoides and Sezary syndrome [J].
Diamandidou, E ;
Cohen, PR ;
Kurzrock, R .
BLOOD, 1996, 88 (07) :2385-2409
[2]   The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment [J].
Greenhough, Alexander ;
Smartt, Helena J. M. ;
Moore, Amy E. ;
Roberts, Heather R. ;
Williams, Ann C. ;
Paraskeva, Christos ;
Kaidi, Abderrahmane .
CARCINOGENESIS, 2009, 30 (03) :377-386
[3]   Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung [J].
Harris R.E. .
Inflammopharmacology, 2009, 17 (2) :55-67
[4]  
Harris Randall E, 2007, Subcell Biochem, V42, P93
[5]   Mycosis fungoides and Sezary syndrome [J].
Hwang, Sam T. ;
Janik, John E. ;
Jaffe, Elaine S. ;
Wilson, Wyndham H. .
LANCET, 2008, 371 (9616) :945-957
[6]   COX-2-dependent PGE2 acts as a growth factor in mycosis fungoides (MF) [J].
Kopp, K. L. M. ;
Kauczok, C. S. ;
Lauenborg, B. ;
Krejsgaard, T. ;
Eriksen, K. W. ;
Zhang, Q. ;
Wasik, M. A. ;
Geisler, C. ;
Ralfkiaer, E. ;
Becker, J. C. ;
Odum, N. ;
Woetmann, A. .
LEUKEMIA, 2010, 24 (06) :1179-1185
[7]  
KREJSGAARD T, 2010, EXP DERMATOL, DOI DOI 10.1111/J.1600-0625.2010.01138.X
[8]   How I treat mycosis fungoides and Sezary syndrome [J].
Prince, H. Miles ;
Whittaker, Sean ;
Hoppe, Richard T. .
BLOOD, 2009, 114 (20) :4337-4353